Posts Categorized: blog

Ask An Expert – What you should know about the newest therapy options.

Our MG community took note of the recent news regarding the latest therapy options that aim to reduce the burden of hours-long treatment delivery with IVIG. For those who are responding well to this new treatment, it’s a game changer. But we recognize that many patients are interesting in learning more, so here are some… Read more »

Conquer MG is seeking new Board of Trustees

Conquer MG is seeking nominations for qualified individuals to serve on its Board of Trustees. This is an incredible group of people who care deeply about the well-being of those who experience or know someone with myasthenia gravis. Our role as board members is to help people with myasthenia gravis and their caregivers access information,… Read more »

Untold Stories: Life with Myasthenia Gravis – A podcast

From our partner, argenx is a new podcast, the “Untold Stories: Life with Myasthenia Gravis.” Take a listen to the first season that explores the real and untold stories of life with myasthenia gravis (MG), finding hope and community in each MG journey.

Argenx Announces New MG Therapy

Argenx Announces U.S. FDA Approval of Vyvgart Hytrulo Injection for Subcutaneous Use in Generalized MG What you need to know: Argenx announced FDA approval for Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc), a subcutaneous injection for adult gMG patients who are anti-acetylcholine receptor (AChR) antibody positive. Delivered via injection instead of through an IV infusion, the… Read more »